Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

New class action for Fractyl (GUTS) urges investors to seek recovery for alleged securities fraud vi

Investors allege Fractyl Health overstated the clinical efficacy of its Revita DMR System while oper

NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

LOS ANGELES, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors o

Two consecutive trading sessions erased roughly 74.86% of Fractyl Health's share value after the Com

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

If you purchased or acquired Fractyl securities between January 13, 2025 and January 29, 2026 and wo

BENSALEM, Pa., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors th

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has

A securities class action alleges Fractyl Health's SEC filings omitted disclosures required under It

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has

LOS ANGELES, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors o

A chronology of dated disclosure events allegedly shows Fractyl Health promoting Revita DMR weight-m

New class action for Fractyl (GUTS) urges investors to seek recovery for alleged securities fraud vi

Fractyl Health, Inc. (NASDAQ: GUTS - Get Free Report) shares hit a new 52-week low during mid-day tr

SAN DIEGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investo

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

If you purchased or acquired Fractyl securities between January 13, 2025 and January 29, 2026 and wo

Fractyl Health (NASDAQ:GUTS) reported quarterly losses of $(0.16) per share which missed the analyst

Fractyl Health reported one-year REMAIN-1 data showing Revita reduced weight regain after GLP-1 ther

Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday&#3

Key Findings:Dose-dependent durability confirmed at one year: In the full modified intention-to-trea

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a B

Participants retained ~78% of GLP-1 induced total body weight loss one year after discontinuation an

Fractyl Health (NASDAQ:GUTS) reported quarterly earnings of $0.06 per share which beat the analyst c

Authorization advances Fractyl Health to a dual clinical-stage company, with Revita in pivotal devel

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a B

Fractyl Health's shares jumped 20.9% after hours following its Q4 2025 results and new weight-ma

Fractyl Health (NASDAQ:GUTS) reported quarterly losses of $(0.07) per share which beat the analyst c

Topline 6-month pivotal data expected in early Q4 2026 with potential FDA marketing application subm

Morgan Stanley analyst Michael Ulz downgrades Fractyl Health (NASDAQ:GUTS) from Overweight to Equ

Fractyl Health stock plunged after the company signaled a possible FDA path change for its Revita de

Revita-treated patients experienced sustained weight maintenance, improved cardiometabolic profile,

RevitaIn 2026, the Company plans to advance Revita through a series of important clinical and regula

Fractyl Health, Inc. (NASDAQ:GUTS) (the "Company" or "Fractyl"), a metabolic therape